4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-19-054774
Director sold 7,500 shares at $52.00 ($390,000)
- Director acquired 7,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| CAGNONI PABLO J Director | 2019-10-30 | Option exercise | +7,500 | $5.59 | $41,925 | 7,500 | D |
| CAGNONI PABLO J Director | 2019-10-30 | Sale | −7,500 | $52.00 | $390,000 | 0 | D |
| Derivatives | |||||||
| CAGNONI PABLO J Director | 2019-10-30 | Option exercise · Stock Option (Right to Buy) | −7,500 | 78,833 | D | ||
| Open-market sales · 7,500 sh · avg $52.00 · $390,000 | |||||||
Loading xslF345X03/doc4.xml…